LHL-clinics Feiring
Feiring, 2093, Norway
NCT Number: NCT02923518
In 2010 there was published new European recommendations for assessment of adult and elderly men and women, who want to start with physical activity and/or participate in endurance contests. In this study we want to test if a group of people with positive score on a self-reported questionnaire and/or high-risk score in a risk scoring system (NORRISK) have more undetected heart diseases than a control group with no reported or detected risk factors.
Looking for future studies?
Notify Me35 year–85 year
All sexes
Observational
Feiring, 2093, Norway
Forty senior athletes between 35 to approximately 80 yrs old with a positive score will be included in one group, and another forty seniors without positive score in a control group. Each of them will be tested with an cardiorespiratory exercise test (CPET) with ECG and examined with echocardiography together with an usual medical examination and blood tests (cholesterol and HbA1c-glucose). Some with symptoms of arrhythmias will be examined by 24-hours Holter-monitoring.
The main purpose of the study is to assess if men and women with a positive score on the questionnaire og NORRISK-screening (risk calculator for coronary heart disease) have more detectable heart diseases than the control group.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
> 35 yrs old Master athletes Positive score on symptom based questionnaire or high risk score No known heart disease Participated in long-term endurance competitions
Exclusion criteria
< 35 yrs old Known heart disease
Observational study without any intervention described under intervention type
Time frame: One year
Examine if a simple screening program is efficient in detecting heart diseases
LHL Helse
Other
Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes) Who Participate in Long Distance Endurance Training and Competitions.
Acronym: MASTERSCREEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05484882
COVID-19, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00701220
Cardiomyopathies, Cardiomyopathy
Columbus, Ohio, United States
View Trial DetailsNCT01605552
Arterial Occlusive Diseases, Arteriosclerosis
Indianapolis, Indiana, United States
View Trial DetailsNCT03579641
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Birmingham, Alabama, United States
View Trial Details